SHR-1210 Plus Apatinib in Patients With Hepatocellular Carcinoma After Surgery

NCT03722875 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

45

Enrollment

OTHER

Sponsor class

Conditions

Hepatocellular Carcinoma

Interventions

DRUG: SHR-1210
DRUG: apatinib

Sponsor

Shanghai Zhongshan Hospital